amit@unlistedkraft.in
+91-9599071664
+91-9599071664
Gynofem Healthcare Unlisted Shares
DRHP Status : Not Filed
59
Fundamentals About Gynofem Healthcare
Downloads & Investor Documents
All documents are provided for informational purposes and are subject to regulatory disclosures.
Key Financials of Gynofem Healthcare
About Company
Gynofem Healthcare and Pharmaceuticals Limited (formerly Pvt Ltd), incorporated in 2022 and based in Indore, is a rapidly growing company specializing in gynecology, obstetrics, and IVF products. It operates a GMP-certified facility producing medications for fertility and pregnancy, with a focus on expanding its market presence across India.
The following table shows a 10-point analysis of Gynofem Healthcare and Pharmaceuticals Limited. We will discuss each point in detail after this table.
| Parameter | Key Numbers | Insights |
|---|---|---|
| Business Overview | Incorporated 2022 | A newly established pharma company focused on women’s healthcare, currently in early growth and expansion phase. |
| Industry | Pharmaceuticals · Women Healthcare | Operates in a niche segment driven by rising demand for fertility, hormonal, and maternal healthcare solutions. |
| Core Products | Gynecology · fertility · hormonal medicines | Focused product portfolio targeting women’s health ensures specialized positioning in the pharma segment. |
| Manufacturing | GMP-certified facility | Strong compliance standards support product quality and regulatory acceptance across markets. |
| Geography | India-focused operations | Initial presence in regional markets with plans to expand distribution nationwide. |
| Revenue | ₹4.37 Cr (FY24) | Early-stage revenue generation with significant YoY growth from a low base. |
| Profitability | ₹-9.20 Cr PAT (FY24) | Losses driven by high operating and expansion costs typical for new pharma companies. |
| Balance Sheet | Assets ₹11.05 Cr | Asset base reflects initial investment in intangibles, inventory, and working capital. |
| Debt Position | Low borrowings (₹0.65 Cr) | Limited leverage indicates controlled financial risk despite the expansion phase. |
| Capital Base | Paid-up capital ₹9.92 Cr | Strong capital backing provides support for scaling operations and R&D investments. |
Company Overview
(i) Gynofem Healthcare and Pharmaceuticals Limited is a pharmaceutical company focused on women’s healthcare, including fertility, hormonal treatments, and maternal wellness products.
(ii) Incorporated in October 2022 and headquartered in Indore, the company operates in the drug formulation and healthcare segment.
(iii) Its product portfolio includes ovulation induction drugs, hormonal therapies, pregnancy supplements, and gynecological care medicines, targeting a growing healthcare need.
(iv) The company operates with GMP and ISO-compliant manufacturing standards, ensuring quality and regulatory adherence in pharmaceutical production.
(v) Gynofem is currently in a scaling phase, expanding its distribution network and investing in R&D for specialized formulations in women’s health.
Challenges in Gynofem Healthcare and Pharmaceuticals Limited’s Business
- Early-stage financial profile: Limited operating history and ongoing losses due to initial scaling phase.
- High R&D and compliance costs: Pharmaceutical business requires continuous investment in product development and regulatory approvals.
- Market competition: Faces competition from established pharma companies in gynecology and fertility segments.
- Distribution expansion challenges: Scaling from regional to national presence requires strong distribution partnerships and execution.
Financial Review of Gynofem Healthcare and Pharmaceuticals Limited
Here are some highlights of the financial performance of Gynofem Healthcare and Pharmaceuticals Limited over the past few years.
FY24 Performance
• Revenue from operations stood at ₹4.37 crore
• Profit before tax stood at ₹-4.79 crore
• Profit after tax reported at ₹-9.20 crore
• Losses driven by employee costs, expansion, and initial setup
FY23 Performance
• Revenue from operations stood at ₹1.34 crore
• Profit after tax reported at ₹-5.21 crore
• Initial year of operations with limited scale
FY22 Performance
• Incorporated in October 2022
• Business setup and initial operations phase
• No significant revenue recorded
Quick Summary
Gynofem Healthcare and Pharmaceuticals Limited is an early-stage pharmaceutical company focused on women’s healthcare, operating in a niche but growing segment. While the company has shown initial revenue traction and strong capital backing, it remains loss-making due to expansion and setup costs, making it a high-risk, high-growth opportunity.
Promoters of Gynofem Healthcare and Pharmaceuticals Limited
Given below are the active promoters of the company:
| Name | Designation | LinkedIn Profile |
|---|---|---|
| Nishi Kant Joshi | Director | View Profile |
| Kartikay Joshi | Director | -- |
| Anurag Mendhe | Director | -- |
Shareholding Pattern of Gynofem Healthcare
Latest News
Latest Post
Coming soon...
Coming soon...
Frequently Asked Questions
These are equity shares of the company that are not listed on NSE or BSE and are traded privately.
Yes, these shares can be purchased through private market platforms, subject to availability.
Yes, a demat account is required to hold these unlisted shares.
The company operates in a high-growth niche but is currently loss-making and early-stage, making it a high-risk investment.
Yes, these shares can be sold in the secondary market depending on buyer availability.
Yes, as per SEBI regulations, pre-IPO investors are subject to a six-month lock-in period after listing.
If held for more than two years, gains are taxed at 20% with indexation; otherwise taxed as per income slab.
+91-9599071664
amit@unlistedkraft.in